Retension Pharmaceuticals, Inc. (RTSN)
10.69
-0.03
(-0.28%)
USD |
NASDAQ |
Nov 06, 10:17
Retension Pharmaceuticals Total Assets (Quarterly) : 16.13M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.13M |
| Date | Value |
|---|---|
| March 31, 2026 | 16.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 147.68B |
| Abeona Therapeutics, Inc. | 179.51M |
| America Great Health | 0.1671M |
| Acumen Pharmaceuticals, Inc. | 85.56M |
| Aardvark Therapeutics, Inc. | 81.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.05M |
| Shareholders Equity (Quarterly) | -14.92M |
| Debt to Equity Ratio | -1.888 |
| Current Ratio | 5.609 |